Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orchestra BioMed Holdings (OBIO) Current Assets (2022 - 2025)

Historic Current Assets for Orchestra BioMed Holdings (OBIO) over the last 4 years, with Q3 2025 value amounting to $97.8 million.

  • Orchestra BioMed Holdings' Current Assets rose 4261.67% to $97.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $97.8 million, marking a year-over-year increase of 4261.67%. This contributed to the annual value of $69.2 million for FY2024, which is 2237.92% down from last year.
  • Orchestra BioMed Holdings' Current Assets amounted to $97.8 million in Q3 2025, which was up 4261.67% from $35.9 million recorded in Q2 2025.
  • Over the past 5 years, Orchestra BioMed Holdings' Current Assets peaked at $129.9 million during Q1 2023, and registered a low of $872555.0 during Q3 2022.
  • Over the past 4 years, Orchestra BioMed Holdings' median Current Assets value was $69.2 million (recorded in 2024), while the average stood at $66.9 million.
  • Its Current Assets has fluctuated over the past 5 years, first skyrocketed by 1252831.57% in 2023, then plummeted by 4602.67% in 2025.
  • Quarter analysis of 4 years shows Orchestra BioMed Holdings' Current Assets stood at $84.7 million in 2022, then rose by 5.22% to $89.1 million in 2023, then decreased by 22.38% to $69.2 million in 2024, then surged by 41.34% to $97.8 million in 2025.
  • Its Current Assets was $97.8 million in Q3 2025, compared to $35.9 million in Q2 2025 and $51.9 million in Q1 2025.